Another report indicated that PRPF19 expression was elevated in most hepatocellular carcinoma tissues and cell lines, and its overexpression correlated positively with vascular invasion and tumor capsule breakthrough, probably through the p38 mitogen-activated protein kinase/twist1 pathway [49]. The gene discussed is MAPK14; the disease is hepatocellular carcinoma.